Iadademstat, Gilteritinib Oral Tablet
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, In Relapse
Phase I
Active Not Recruiting
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)
Sep 15, 2022
―
Vafidemstat
Borderline Personality Disorder
Phase II
Completed
Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population
Apr 12, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Oryzon Genomics SA (ORYN) have in its pipeline
ORYN is currently developing the following drugs: Iadademstat, Gilteritinib Oral Tablet, Vafidemstat. These drug candidates are in various stages of clinical development as the company works toward FDA approval.